Joint disease in the horse is the number one cause of ongoing lameness and a result of many factors including excessive or ongoing trauma, genetics, diet and lifestyle influences. Degeneration within the joint leads to cartilage erosion, remodeling of the joint, ongoing pain and reduced range of motion in more severe cases. It is a condition that is best prevented and managed in the early stages versus in the advanced stages.
Therapies for joint disease in the horse now includes joint injections with corticosteroids, hyaluronic acid, polysulfated glycosaminoglycans and over the past several years, there is a new kid on the block termed IRAP or Interleukin-1 Receptor Antagonist Protein. IRAP therapy is supposed to help manage the inflammation and joint deterioration more effectively through the use of the body’s own natural resources.